With expiration of exemptions impacting manufacturers first, quickly followed by wholesalers and dispensers, the pharmaceutical industry is at a critical point for alignment to ensure interoperable data exchange. Facilitated by a leading industry association, supply chain stakeholders will detail significant developments in meeting requirements, including the evolution of data handling and the shift from establishing connections to managing exceptions effectively. Current success rate and challenges in data transmission will be examined along with outlining steps manufacturers can take to help enable product verification. Join this session to see how industry is coming together to finish the last mile of DSCSA.